Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Regional nerve blocks are better than ring blocks for pain relief during PRP hair treatment.

Cuscuta reflexa extract may help treat benign prostatic hyperplasia by reducing inflammation and oxidative stress.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Erythrocyte-anchored nanoparticles improved Cepharanthine delivery and effectiveness for treating acute lung injury.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

MC-1R is present in skin cells and may help reduce inflammation.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Finasteride may help reduce impulsivity caused by pramipexole.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.